(Q39750245)

14 September 2017

title

Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area (English)

1 reference

14 September 2017

Li-Yu Wang

1

1 reference

14 September 2017

Chi-Tan Hu

series ordinal

2

1 reference

14 September 2017

Tzu-Ying Ho

series ordinal

3

1 reference

14 September 2017

Hans Hsienhong Lin

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

10 March 2006

1 reference

14 September 2017

1 reference

14 September 2017

volume

24

1 reference

14 September 2017

issue

20

1 reference

14 September 2017

page(s)

4427-4432

1 reference

Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Hepatitis B e antigen and the risk of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Epidemiology of hepatitis B virus infection in the Asia-Pacific region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Vertical Transmission of Hepatitis B Antigen in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Hepatitis B vaccination: universal vaccination of newborn babies and children at 12 years of age versus high risk groups. A comparison in the field

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children: a 12-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Marked decrease of hepatitis B virus infection among children in Okinawa, Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

Trend of hepatitis B virus infection in freshmen classes at two high schools in Hualien, Taiwan from 1991 to 1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.12.069

10.1016/J.VACCINE.2005.12.069

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference